Pub Date : 2023-08-22DOI: 10.2174/2468187313666230822101717
Ankit Srivastava, Biswajita Pradhan, B. P. Jit, Kaushik Kumar Bharadwaj, Deeksha Rikhari
Nanotechnology involves the study of different materials on the nanometer scale, typically less than 100 nm in size. Nanomedicine is the creation of nanotechnology, a new science and technology area. Similarly, various nanomaterials, such as nanostructure, nanotubes, and nanoparticles, were also found to have significant applications in the human biological system at the molecular level to achieve healthcare advantage. Nanotechnology is rapidly expanding in the field of medicine with a special emphasis on ophthalmology. Nanotechnology advancements need to be translated into a new and exciting platform for diagnosis, treatment, and therapeutics for ocular disease. The application of nanotechnology in ocular disease and cancer, such as nanoparticle-based drug delivery system, drug development, gene therapy, and tissue engineering, helps overcome many ocular problems. In particular, one of the most important applications of the emerging nanoscience system is used in ocular cancer diagnosis and therapy with the help of carbon nanotubes, nanocrystals, nanowires, etc. Several approaches have been developed for treatment and therapy for ocular disease. Moreover, these tremendous approaches have been safely used and effective for a broad range of applications. In this study, the focus is to discuss recent findings and various constraints and summarize the applications of nanotechnology-mediated systems for treating various ocular diseases.
{"title":"Advancement in Nanobiotechnology for Human Health Care: Focus on Ocular Diseases and Future Prospects","authors":"Ankit Srivastava, Biswajita Pradhan, B. P. Jit, Kaushik Kumar Bharadwaj, Deeksha Rikhari","doi":"10.2174/2468187313666230822101717","DOIUrl":"https://doi.org/10.2174/2468187313666230822101717","url":null,"abstract":"\u0000\u0000Nanotechnology involves the study of different materials on the nanometer scale, typically less than 100 nm in size. Nanomedicine is the creation of nanotechnology, a new science and technology area. Similarly, various nanomaterials, such as nanostructure, nanotubes, and nanoparticles, were also found to have significant applications in the human biological system at the molecular level to achieve healthcare advantage. Nanotechnology is rapidly expanding in the field of medicine with a special emphasis on ophthalmology. Nanotechnology advancements need to be translated into a new and exciting platform for diagnosis, treatment, and therapeutics for ocular disease. The application of nanotechnology in ocular disease and cancer, such as nanoparticle-based drug delivery system, drug development, gene therapy, and tissue engineering, helps overcome many ocular problems. In particular, one of the most important applications of the emerging nanoscience system is used in ocular cancer diagnosis and therapy with the help of carbon nanotubes, nanocrystals, nanowires, etc. Several approaches have been developed for treatment and therapy for ocular disease. Moreover, these tremendous approaches have been safely used and effective for a broad range of applications. In this study, the focus is to discuss recent findings and various constraints and summarize the applications of nanotechnology-mediated systems for treating various ocular diseases.\u0000","PeriodicalId":10818,"journal":{"name":"Current Nanomedicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46636158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-21DOI: 10.2174/2468187313666230821153922
A. Mohamed, Dalia Yousry Saad, H. Khalil, Asmaa E. Farouk, A. Soliman
Gentamicin (GM) is an antibiotic frequently used to treat severe gram-negative infections. However, due to nephrotoxicity, its clinical application is restricted. Several lines of evidence indicate that free radicals are important mediators of gentamicin nephrotoxicity. Therefore, the purpose of this research was to examine the potential antioxidant therapeutic value of ZnO-chitosan nanoparticles on gentamicin-induced nephrotoxicity. Twenty-four rats were divided into four groups (6 rats/group). All groups except group 1 were injected with gentamicin (100 mg/kg body weight i.p.) for eight days. On day 9, rats of groups 1 and 2 were administrated distilled water, and those of groups 3 and 4 were administrated 1/10 and 1/20 LD50 of ZnO-CS-NPs continuously for 30 days. Treatment with ZnO-CS NPs caused a significant decrease in urea, creatinine, uric acid, sodium, potassium, chloride, microalbumin, and malondialdehyde levels; this was accompanied by a significant increase in kidney glutathione reduced, nitric oxide, superoxide dismutase, glutathione S-transferase, and catalase. The findings of the current study revealed that ZnO-CS NP ameliorated kidney injury against gentamicin induced-acute kidney injury in rats by its antioxidant properties.
{"title":"Therapeutic effect of Chitosan-Zinc oxide nanoparticles on acute kidney injury induced by gentamicin in Wistar rats","authors":"A. Mohamed, Dalia Yousry Saad, H. Khalil, Asmaa E. Farouk, A. Soliman","doi":"10.2174/2468187313666230821153922","DOIUrl":"https://doi.org/10.2174/2468187313666230821153922","url":null,"abstract":"\u0000\u0000Gentamicin (GM) is an antibiotic frequently used to treat severe gram-negative infections. However, due to nephrotoxicity, its clinical application is restricted. Several lines of evidence indicate that free radicals are important mediators of gentamicin nephrotoxicity. Therefore, the purpose of this research was to examine the potential antioxidant therapeutic value of ZnO-chitosan nanoparticles on gentamicin-induced nephrotoxicity.\u0000\u0000\u0000\u0000Twenty-four rats were divided into four groups (6 rats/group). All groups except group 1 were injected with gentamicin (100 mg/kg body weight i.p.) for eight days. On day 9, rats of groups 1 and 2 were administrated distilled water, and those of groups 3 and 4 were administrated 1/10 and 1/20 LD50 of ZnO-CS-NPs continuously for 30 days.\u0000\u0000\u0000\u0000Treatment with ZnO-CS NPs caused a significant decrease in urea, creatinine, uric acid, sodium, potassium, chloride, microalbumin, and malondialdehyde levels; this was accompanied by a significant increase in kidney glutathione reduced, nitric oxide, superoxide dismutase, glutathione S-transferase, and catalase.\u0000\u0000\u0000\u0000The findings of the current study revealed that ZnO-CS NP ameliorated kidney injury against gentamicin induced-acute kidney injury in rats by its antioxidant properties.\u0000","PeriodicalId":10818,"journal":{"name":"Current Nanomedicine","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45082690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-08-21DOI: 10.2174/2468187313666230821102705
S. Dizaj, Yashar Rezaei, Leila Javadikia, Simin Sharifi, Amirreza Khosroshahi
The aim of this study was to prepare gelatin-nanocurcumin/nanohydroxy apatite nanofibers and test the effect of nanohydroxyapatite and nanocurcumin on the tensile strength of gelatin nanofibers. Finding the ideal bone replacement material has long been the focus of research in the field of bone regeneration. This study also aimed to assess the effect of adding nanohydroxyapatite and nanocurcumin on the tensile strength of gelatin nanofibers in order to propose an ideal nanofiberous scaffold for bone regeneration application. Gelatin-curcumin nanofibers were prepared using an electrospinning method with a ratio of 70% to 30% of gelatin and curcumin and 5% of hydroxyapatite. Adding curcumin to the gelatin nanofiber structure increased its tensile strength in the wet state (21.03 ± 2.17 to 28.54 ± 0.59, p < 0.0001). Besides, adding nanohydroxyapatite to the structure of gelatin nanofibers increased its tensile strength in dry (30.31 ± 0.64 to 35.79 ± 1.13, p <